COMPASS THERAPEUTICS, INC. Financing Cash Flow
COMPASS THERAPEUTICS, INC. (CMPX) reported Financing Cash Flow of $3.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.37M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.06M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $129.36M.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $129.61M, a 647.54% increase from fiscal 2024.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $17.34M, a 490.73% increase from fiscal 2023.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $2.94M, a 96.13% decline from fiscal 2022.
- COMPASS THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $75.76M, a 36.13% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 0 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.37M 10-Q · filed 2026-08-06 | $4.43M derived: sum of 3 quarters · filed 2026-08-06 | $133.79M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $3.37M 10-Q · filed 2026-05-05 | $4.43M derived: sum of 2 quarters · filed 2026-05-05 | $133.79M derived: sum of 3 quarters · filed 2026-05-05 | $133.79M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $130.42M derived: sum of 2 quarters · filed 2026-03-05 | $130.42M derived: sum of 3 quarters · filed 2026-08-06 | $129.61M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $129.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $129.36M derived: sum of 2 quarters · filed 2026-08-06 | $128.55M 10-Q · filed 2025-11-05 | $128.45M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$815.00K 10-Q · filed 2026-08-06 | -$909.00K derived: sum of 3 quarters · filed 2026-08-06 | -$911.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$815.00K 10-Q · filed 2026-05-05 | -$909.00K derived: sum of 2 quarters · filed 2026-05-05 | -$911.00K derived: sum of 3 quarters · filed 2026-05-05 | -$910.00K derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$96.00K derived: sum of 2 quarters · filed 2026-03-05 | -$95.00K derived: sum of 3 quarters · filed 2026-03-05 | $17.34M 10-K · filed 2026-03-05 | |
| 2024-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.00K derived: sum of 2 quarters · filed 2025-11-05 | $17.43M 10-Q · filed 2025-11-05 | $17.27M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $17.43M 10-Q · filed 2025-08-11 | $17.28M derived: sum of 3 quarters · filed 2025-08-11 | $17.30M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | $17.43M 10-Q · filed 2025-05-08 | $17.27M derived: sum of 2 quarters · filed 2025-05-08 | $17.30M derived: sum of 3 quarters · filed 2025-05-08 | $20.33M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$137.00K derived: sum of 2 quarters · filed 2025-02-27 | $2.89M derived: sum of 3 quarters · filed 2025-02-27 | $2.94M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.05M derived: sum of 2 quarters · filed 2024-11-12 | $3.09M 10-Q · filed 2024-11-12 | $78.84M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $3.07M 10-Q · filed 2024-08-12 | $78.82M derived: sum of 3 quarters · filed 2024-08-12 | $78.83M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $41.00K 10-Q · filed 2024-05-13 | $75.79M derived: sum of 2 quarters · filed 2024-05-13 | $75.80M derived: sum of 3 quarters · filed 2024-05-13 | $75.80M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $75.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $75.76M derived: sum of 2 quarters · filed 2024-03-21 | $75.76M derived: sum of 3 quarters · filed 2024-03-21 | $75.76M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.00K derived: sum of 2 quarters · filed 2023-11-09 | $5.00K 10-Q · filed 2023-11-09 | $124.24M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $124.24M derived: sum of 3 quarters · filed 2023-08-03 | $122.36M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $124.24M derived: sum of 2 quarters · filed 2023-05-04 | $122.36M derived: sum of 3 quarters · filed 2023-05-04 | $120.49M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $124.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $122.36M derived: sum of 2 quarters · filed 2023-03-15 | $120.49M derived: sum of 3 quarters · filed 2023-03-15 | $118.61M 10-K · filed 2023-03-15 | |
| 2021-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.75M derived: sum of 2 quarters · filed 2022-11-09 | -$5.63M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$3.75M 10-Q · filed 2021-08-16 | |||
| 2021-06-20 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | -$3.75M 10-Q · filed 2022-08-01 | -$5.63M derived: sum of 3 quarters · filed 2022-08-01 | -$8.30M derived: sum of 4 quarters · filed 2022-08-01 | |
| 2021-03-31 | -$1.88M 10-Q · filed 2022-05-09 | -$3.75M derived: sum of 2 quarters · filed 2022-05-09 | -$6.43M derived: sum of 3 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$4.55M derived: sum of 2 quarters · filed 2022-03-18 | $48.54M 10-K · filed 2022-03-18 | ||
| 2020-09-30 | -$2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $50.41M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $53.09M 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-08 | $17.50K derived: sum of 2 quarters · filed 2020-06-08 | $30.98K 10-K · filed 2020-06-08 | ||
| 2019-12-31 | $7.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | $20.98K 10-Q · filed 2020-02-14 | |||
| 2019-09-30 | $13.48K 10-Q · filed 2019-11-13 | ||||
| 2019-03-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-08 | $22.50K derived: sum of 2 quarters · filed 2020-06-08 | $22.50K derived: sum of 3 quarters · filed 2020-06-08 | $37.63K 10-K · filed 2020-06-08 | |
| 2018-12-31 | $12.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | $12.50K derived: sum of 2 quarters · filed 2020-02-14 | $27.63K 10-Q · filed 2020-02-14 | ||
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-13 | $15.13K 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | $15.13K 10-Q · filed 2019-08-13 | ||||
| 2018-03-31 | $35.00K 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |